Transcription variants of the prostate-specific PrLZ gene and their interaction with 14-3-3 proteins

Biochemical and Biophysical Research Communications

Volumn 389, Issue 3, 2009, Pages 455-460

  Wang, Ruoxiang ^a   He, Hui ^b   Sun, Xiaojuan ^a   Xu, Jianchun ^a   Marshall, Fray F ^a   Zhau, Haiyen ^a   Chung, Leland W K ^a   Fu, Haian ^a   He, Dalin ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Alternative splicing; Mammalian two hybrid assay; PrLZ gene; Prostate specific gene; Protein interaction 14 3 3

Indexed keywords

ISOPROTEIN; PROTEIN 14 3 3; TPD52 PROTEIN, HUMAN; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; EXON; GENE ISOLATION; GENE STRUCTURE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PRLZ GENE; PROSTATE; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ALTERNATIVE RNA SPLICING; GENETICS; METABOLISM; MOLECULAR GENETICS; PROSTATE TUMOR; TUMOR CELL LINE;

MAMMALIA;

14-3-3 PROTEINS; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; CELL LINE, TUMOR; CONSERVED SEQUENCE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; TRANSCRIPTION, GENETIC;

EID: 70449726622     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.165     Document Type: Article

References (24)

1. I.E. Eder, J. Bektic, P. Haag, G. Bartsch, H. Klocker, Genes differentially expressed in prostate cancer, BJU Int. 93 (2004) 1151-1155.
2. E.P. Gelmann, O.J. Semmes, Expression of genes and proteins specific for prostate cancer, J. Urol. 172 (2004) S23-S26 (Discussion S26-S27).
3. R.B. Myers, W.E. Grizzle, Changes in biomarker expression in the development of prostatic adenocarcinoma, Biotech. Histochem. 72 (1997) 86-95.
4. G. Petrovics, W. Zhang, M. Makarem, J.P. Street, R. Connelly, L. Sun, I.A. Sesterhenn, V. Srikantan, J.W. Moul, S. Srivastava, Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients, Oncogene 23 (2004) 605-611.
5. R. Wang, J. Xu, N. Mabjeesh, G. Zhu, J. Zhou, M. Amin, D. He, F.F. Marshall, H.E. Zhau, L.W. Chung, PrLZ is expressed in normal prostate development and in human prostate cancer progression, Clin. Cancer Res. 13 (2007) 6040-6048.
6. X. Fu, L. Ravindranath, N. Tran, G. Petrovics, S. Srivastava, Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1, DNA Cell Biol. 25 (2006) 135-141.
7. G.U. Dachs, G.J. Dougherty, I.J. Stratford, D.J. Chaplin, Targeting gene therapy to cancer: a review, Oncol Res. 9 (1997) 313-325.
8. C.L. Hsieh, L.W. Chung, New prospectives of prostate cancer gene therapy: molecular targets and animal models, Crit. Rev. Eukaryot. Gene Expr. 11 (2001) 77-120.
9. R. Wang, J. Xu, O. Saramaki, T. Visakorpi, W.M. Sutherland, J. Zhou, B. Sen, S.D. Lim, N. Mabjeesh, M. Amin, J.T. Dong, J.A. Petros, P.S. Nelson, F.F. Marshall, H.E. Zhau, L.W. Chung, PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer, Cancer Res. 64 (2004) 1589-1594.
10. T. Visakorpi, A.H. Kallioniemi, A.C. Syvanen, E.R. Hyytinen, R. Karhu, T. Tammela, J.J. Isola, O.P. Kallioniemi, Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization, Cancer Res. 55 (1995) 342-347.
11. J.A. Byrne, M.G. Mattei, P. Basset, Definition of the tumor protein D52 (TPD52) gene family through cloning of D52 homologues in human (hD53) and mouse (mD52), Genomics 35 (1996) 523-532.
12. T. Dagan, Y. Talmor, D. Graur, Ratios of radical to conservative amino acid replacement are affected by mutational and compositional factors and may not be indicative of positive Darwinian selection, Mol. Biol. Evol. 19 (2002) 1022-1025.
13. C.R. Vinson, P.B. Sigler, S.L. McKnight, Scissors-grip model for DNA recognition by a family of leucine zipper proteins, Science 246 (1989) 911-916.
14. R. Boutros, A.M. Bailey, S.H. Wilson, J.A. Byrne, Alternative splicing as a mechanism for regulating 14-3-3 binding: interactions between hD53 (TPD52L1) and 14-3-3 proteins, J. Mol. Biol. 332 (2003) 675-687.
15. R. Boutros, J.A. Byrne, D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cells, Exp. Cell Res. 310 (2005) 152-165.
16. G. Tzivion, J. Avruch, 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation, J. Biol. Chem. 277 (2002) 3061-3064.
17. M.B. Yaffe, A.E. Elia, Phosphoserine/threonine-binding domains, Curr. Opin. Cell Biol. 13 (2001) 131-138.
18. M. Irimia, J.L. Rukov, S.W. Roy, J. Vinther, J. Garcia-Fernandez, Quantitative regulation of alternative splicing in evolution and development, BioEssays 31 (2009) 40-50.
19. T. Moroy, F. Heyd, The impact of alternative splicing in vivo: mouse models show the way, RNA 13 (2007) 1155-1171.
20. J. Tazi, N. Bakkour, S. Stamm, Alternative splicing and disease, Biochim. Biophys. Acta 1792 (2009) 14-126.
21. T.A. Cooper, W. Mattox, The regulation of splice-site selection, and its role in human disease, Am. J. Hum. Genet. 61 (1997) 259-266.
22. P. Rajan, D.J. Elliott, C.N. Robson, H.Y. Leung, Alternative splicing and biological heterogeneity in prostate cancer, Nat. Rev. Urol. 6 (2009) 454-460.
23. D. Lodygin, H. Hermeking, Epigenetic silencing of 14-3-3sigma in cancer, Semin. Cancer Biol. 16 (2006) 214-224.
24. K. Horie-Inoue, S. Inoue, Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers, Semin. Cancer Biol. 16 (2006) 235-239.